FDA Inspection 1053977 — Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. on May 11, 2018 in Hangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 11, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hangzhou (China)